"Antipsychotic & Bipolar Disorder Agents." Katzung & Trevor's Pharmacology: Examination & Board Review, 13e Eds. Bertram G. Katzung, et al. McGraw Hill, 2021
Raj, Kristin S., et al. "Schizophrenia Spectrum Disorders." Current Medical Diagnosis & Treatment 2021 Eds. Maxine A. Papadakis, et al. McGraw Hill, 2021
Neuroleptics ADEs: QT Effects https://www.crediblemeds.org/healthcare-providers
Adverse factors associated with atypical antipsychotic medications (listed in alphabetical order). Current Medical Diagnosis & Treatment 2021 Eds. Maxine A. Papadakis, et al. McGraw Hill, 2021
American Diabetes Association et al. “Consensus development conference on antipsychotic drugs and obesity and diabetes.” Diabetes care vol. 27,2 (2004): 596-601. doi:10.2337/diacare.27.2.596
Cerovecki, Anja et al. “Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.” CNS drugs vol. 27,7 (2013): 545-72. doi:10.1007/s40263-013-0079-5